Innovations in practice. 5 years of palbociclib experience in the Russian Federation. Overview of web-conference took place on 8 October 2021
The educational cycle "Venus of The Future: the discoveries and new traditions in the treatment of mBC" was initiated by Pfizer with the support of TS Oncology. During several web-conferences planned in 20212022 key experts discussed implementation in clinical practice and availability of...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Habib O.N.
2021-12-01
|
| Series: | Современная онкология |
| Subjects: | |
| Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/100143/73801 |
| Summary: | The educational cycle "Venus of The Future: the discoveries and new traditions in the treatment of mBC" was initiated by Pfizer with the support of TS Oncology. During several web-conferences planned in 20212022 key experts discussed implementation in clinical practice and availability of innovative approaches for treatment patients with HER-negative mBC in the Russian Federation. The first web-conference of the cycle - "Innovations in practice. 5 years of palbociclib experience in the Russian Federation" took place on October 8, 2021 and was dedicated to the 5th anniversary since registration in the Russian Federation of palbociclib 1st CDK4/6 inhibitor (CDK4/6i) in our country. Key Russian experts in oncology, who were at the forefront of introducing CDK4/6i into routine clinical practice, took part in the event and outlined the importance of considering the differences among iCDK 4/6 in terms of the tolerance profile and monitoring requirements, as well as taking into account practical experience when making desicion to choose specific product. Experts agreed that palbociclib have a great advantage over other products in the class due to significant amount of RCT and RWE data, as well as broad practical experience (more than 5 years) in the Russian Federation and in the world. |
|---|---|
| ISSN: | 1815-1434 1815-1442 |